The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Open accessAbstract
Transcription factors of the NF-kappaB/Rel family are critical for inducible expression of multiple genes involved in inflammatory responses. Sulfasalazine and its salicylate moiety 5-aminosalicylic acid are among the most effective agents for treating inflammatory bowel disease and rheumatoid arthritis. However, the mode of action of these drugs remains unclear. Here we provide evidence that the transcription factor NF-kappaB is a target of sulfasalazine-mediated immunosuppression. Treatment of SW620 colon cells with sulfasalazine inhibited TNFalpha-, LPS-, or phorbol ester- induced NF-kappaB activation. NF-kappaB-dependent transcription was inhibited by sulfasalazine at micro- to millimolar concentrations. In contrast, 5-aminosalicylic acid or sulfapyridine did not block NF-kappaB activation at all doses tested. TNFalpha-induced nuclear translocation of NF-kappaB was prevented by sulfasalazine through inhibition of IkappaBalpha degradation. When blocking proteasome-mediated degradation of IkappaBalpha, we could demonstrate that sulfasalazine interfered with IkappaBalpha phosphorylation, suggesting a direct effect on an IkappaBalpha kinase or on an upstream signal. Inhibition of NF-kappaB activation seems to be specific since other DNA-binding activities such as AP1 were not affected. These results demonstrate that sulfasalazine is a potent and specific inhibitor of NF-kappaB activation, and thus may explain some of the known biological properties of sulfasalazine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intriguingly, sulfasalazine, a drug used for decades to treat autoimmune inflammatory bowel disease (IBD) and psoriatic arthritis (Gupta et al., 1990), is now recognized as targeting the BH4 pathway by inhibiting SPR (Haruki et al., 2013), in addition to other targets, such as NFκB (Wahl et al., 1998).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Wahl et al., 1998
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,793
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,002
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,089
Structure, Regulation and Function of NF-kappaB
Siebenlist, U. K., Franzoso, G., & Brown, K. D. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,086
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,744
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,676
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Research works printed but not linked: 1
- [34]34. Chiao, P.J., M. Shigeki, and I.M. Verma. 1994. Autoregulation of I k B a activity. Proc. Natl. Acad. Sci. USA. 91:28-32.
Cited by
Sorted by citations
Items 301–400 of 743
The Novel Neuroprotective Action of Sulfasalazine through Blockade of NMDA Receptors
Ryu, B. R., Lee, Y. A., Won, S. J., Noh, J.-H., Chang, S.-Y., Chung, J.-M., Choi, J., Joo, C. K., Yoon, S. H., & Gwag, B. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042606 · Cited by 41
van der Heijden, J., de Jong, M. C., Dijkmans, B. A. C., Lems, W. F., Oerlemans, R., Kathmann, I., Scheffer, G. L., Scheper, R. J., Assaraf, Y. G., & Jansen, G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.006494 · Cited by 41
Kim, S., Choi, S. C., Choi, E., Kim, K.-S., Oh, J., Lee, H., Oh, H., Kim, S., Oh, B., Kimm, K., et al. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00010 · Cited by 40
Hammer, S., Sauer, B., Spika, I., Schraut, C., Kleuser, B., & Schäfer‐Korting, M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10766 · Cited by 40
In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine
Gout, P. W., Simms, C. R., & Robertson, M. C. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200301000-00004 · Cited by 39
Sol Fustiñana, M., de la Fuente, V., Federman, N., Freudenthal, R., & Romano, A. (2014) · Learning & Memory · doi:10.1101/lm.035998.114 · Cited by 39
Lin, J., Akiyama, M., Bica, I., Long, F. T., Henderson, C. F., Goddu, R. N., Suarez, V., Baker, B., Ida, T., Shinkai, Y., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00340 · Cited by 39
Wahl, C., Maier, S., Marre, R., & Essig, A. (2003) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00274 · Cited by 39
Self-citationKang, Chung, ., I., Choe, & Kim (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00849.x · Cited by 39
Santos-Moreno, P., Rodríguez-Vargas, G.-S., Martínez, S., Ibatá, L., & Rojas‐Villarraga, A. (2022) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s285407 · Cited by 42
Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo
Spiller, S. E., Logsdon, N. J., Deckard, L. A., & Sontheimer, H. W. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-136 · Cited by 40
Kim, S. E., Lee, J. Y., Shim, K.-S., Lee, S., Min, K., Bae, J., Kim, H. J., Park, K., & Song, H. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.03.059 · Cited by 38
Clinical Pharmacokinetics of Slow Release Mesalazine
Vos, M. D. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00001 · Cited by 38
NF-kappaB/Rel Transcriptional Pathway: Implications in Pancreatic Cancer
Algül, H., Adler, G., & Schmid, R. M. (2002) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:31:1-3:71 · Cited by 37
Self-citationSnyder, J. G., Prewitt, R. L., Campsen, J., & Britt, L. D. (2002) · Shock · doi:10.1097/00024382-200204000-00011 · Cited by 38
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
Rousseaux, C., El‐Jamal, N., Fuméry, M., Dubuquoy, C., Romano, O., Chatelain, D., Langlois, A., Bertin, B., Buob, D., Colombel, J. F., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt245 · Cited by 38
Robe, P. A. J. T., Martin, D., Albert, A., Deprez, M., Chariot, A., & Bours, V. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-29 · Cited by 38
NF-κ B as a Molecular Target in the Therapy of Pancreatic Carcinoma
Sebens, S., Arlt, A., & Schäfer, H. (2007) · Springer eBooks · doi:10.1007/978-3-540-71279-4_17 · Cited by 38
Yin, X., Krikorian, P., Logan, T. J., & Csizmadia, V. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0226-y · Cited by 35
Lee, U. J., Choung, S., Prakash, K. V. B., Lee, E., Lee, M. Y., Kim, Y. J., Han, C. W., & Choi, Y.-C. (2007) · Molecular Biology Reports · doi:10.1007/s11033-007-9084-4 · Cited by 37
Mirror, mirror on the wall: which microbiomes will help heal them all?
Nayak, R. R., & Turnbaugh, P. J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0622-6 · Cited by 36
Evolving Treatment Strategies for Inflammatory Bowel Disease
Hanauer, S. B., & Dassopoulos, T. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.299 · Cited by 36
Epidermal growth factor activates nuclear factor-κB in human proximal tubule cells
Häußler, U., von Wichert, G., Schmid, R. M., Keller, F., & Schneider, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00434.2003 · Cited by 35
Self-citationGreen, K. N., & Peers, C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00907.x · Cited by 35
Arsenite enhances tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1
Tsou, T., Yeh, S. C., Tsai, E., Tsai, F., Chao, H., & Chang, L. W. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.03.006 · Cited by 35
Dikopoulos, N., Nussler, A. K., Liptay, S., Bachem, M. G., Reinshagen, M., Stiegler, M., Schmid, R. M., Adler, G., & Weidenbach, H. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00802.x · Cited by 35
Self-citationPharmacologic Treatment Strategies in Psoriatic Arthritis
Ayan, G., Ribeiro, A. L., Macit, B., & Proft, F. N. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.05.010 · Cited by 34
Greene, M. W., Ruhoff, M. S., Burrington, C. M., Garofalo, R. S., & Orena, S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.029 · Cited by 34
Perdomo-Celis, F., Feria, M. G., Taborda, N. A., & Rugeles, M. T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02502 · Cited by 34
Wee, H. N., Neo, S.-Y., Singh, D., Yew, H.-C., Qiu, Z.-Y., Tsai, X.-R. C., How, S.-Y., Yip, K.-Y. C., Tan, C. H., & Koh, H. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02884-w · Cited by 38
Ansari, M. J., Soltani, A., Taghartapeh, M. R., Singla, P., Aghaei, M., Fadafan, H. K., Khales, S. A., Shariati, M., Shirzad‐Aski, H., Balakheyli, H., et al. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.118083 · Cited by 34
Baumgart, D. C., Vierziger, K., Sturm, A., Wiedenmann, B. J., & Dignass, A. U. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510015854 · Cited by 34
Morales, J. C., Ruiz-Magaña, M. J., & Ruiz‐Ruiz, C. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.12.015 · Cited by 34
Tabit, C. E., Holbrook, M., Shenouda, S. M., Dohadwala, M. M., Widlansky, M. E., Frame, A. A., Kim, B. H., Duess, M., Kluge, M. A., Levit, A., et al. (2012) · Vascular Medicine · doi:10.1177/1358863x12440117 · Cited by 35
Sulfasalazine Blocks the Development of Tactile Allodynia in Diabetic Rats
Berti‐Mattera, L. N., Kern, T. S., Siegel, R. E., Nemet, I., & Mitchell, R. D. (2008) · Diabetes · doi:10.2337/db07-1274 · Cited by 34
REGULATION OF TOLL-LIKE RECEPTOR 2 AND 4 GENE EXPRESSION IN MURINE ALVEOLAR MACROPHAGES
Oshikawa, K., & Sugiyama, Y. (2003) · Experimental Lung Research · doi:10.1080/01902140303756 · Cited by 34
Osmotic stress sensitizes naturally resistant cells to TNF-α-induced apoptosis
Franco, D. L., Nojek, I. M., Molinero, L. L., Coso, O. A., & Costas, M. A. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401074 · Cited by 34
Protein kinase C–dependent activation of NF-κB in enterocytes is independent of IκB degradation
Wilson, L. K., Szabó, C., & Salzman, A. L. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70556-1 · Cited by 34
Hellmuth, M., Wetzler, C., Nold, M. F., Chang, J.-H., Frank, S., Pfeilschifter, J. M., & Mühl, H. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1273 · Cited by 34
Immunotherapies in Rheumatologic Disorders
Miller, A. V., & Ranatunga, S. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.04.003 · Cited by 33
Patinote, C., Karroum, N. B., Moarbess, G., Deleuze‐Masquéfa, C., Hadj‐Kaddour, K., Cuq, P., Diab‐Assaf, M., Kassab, I., & Bonnet, P. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.021 · Cited by 33
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis
MacMullan, P., Madigan, A. M., Nevin, P., Peace, A. J., Alagha, A. B. M., Nolan, K. B., McCarthy, G., & Kenny, D. J. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2769-x · Cited by 35
Witthöft, T., Pilz, C. S., Fellermann, K., Nitschke, M., Stange, E. F., & Ludwig, D. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2768-5 · Cited by 34
Jun, C., Kim, Y., Choi, E.-Y., Kim, M. S., Park, B., Youn, B., Yu, K.-Y., Choi, K., Yoon, K., Choi, S. C., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.ibd.0000225340.99108.8a · Cited by 33
de Vries, E. M., Kwakkel, J., Eggels, L., Kalsbeek, A., Barrett, P., Fliers, E., & Boelen, A. (2014) · Endocrinology · doi:10.1210/en.2013-2018 · Cited by 32
Bentea, E., Demuyser, T., Liefferinge, J. V., Albertini, G., Deneyer, L., Nys, J., Merckx, E., Michotte, Y. M., Sato, H., Arckens, L., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.010 · Cited by 33
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in gorlin syndrome
Chaudhary, S. C., Tang, X., Arumugam, A., Li, C., Srivastava, R. K., Weng, Z., Xu, J., Zhang, X., Kim, A. L., McKay, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5103 · Cited by 32
Heidari, R., Esmailie, N., Azarpira, N., Najibi, A., & Niknahad, H. (2016) · Toxicological Research · doi:10.5487/tr.2016.32.2.133 · Cited by 32
Ban, J. O., Oh, J. H., Hwang, B. Y., Moon, D. C., Jeong, H., Lee, S., Kim, S., Lee, H., Kim, K., Han, S., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0694 · Cited by 32
Role of Mesalazine in Acute and Long-Term Treatment of Ulcerative Colitis and Its Complications
Schroeder, K. W. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320621445 · Cited by 32
Dharane, P., Manuelpillai, U., Wallace, E. M., & Walker, D. W. (2010) · Placenta · doi:10.1016/j.placenta.2010.09.002 · Cited by 32
Mechanisms of Disease: transcription factors in inflammatory arthritis
Aud, D., & Peng, S. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0222 · Cited by 33
Is psoriasis a bowel disease? Successful treatment with bile acids and bioflavonoids suggests it is
Ely, P. H. (2018) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2018.03.011 · Cited by 34
O’Sullivan, N. C., Croydon, L., McGettigan, P., Pickering, M., & Murphy, K. J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.11.001 · Cited by 31
The NF-κB inhibitors attenuate hepatic injury in bile duct ligated rats
Demi̇rbi̇lek, S., Akın, M., Gürünlüoğlu, K., Aydın, N. E., Emre, M. H., Taş, E., Aksoy, R. T., & Ay, S. (2006) · Pediatric Surgery International · doi:10.1007/s00383-006-1721-9 · Cited by 31
Improving Delivery of Aminosalicylates in Ulcerative Colitis
Fernandez‐Becker, N., & Moss, A. C. (2008) · Drugs · doi:10.2165/00003495-200868080-00006 · Cited by 31
From willow bark to peptides: the ever widening spectrum of NF-κB inhibitors
D’Acquisto, F., & Ianaro, A. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.009 · Cited by 31
Carbachol Activates IκB Kinase in Isolated Canine Gastric Parietal Cells
Todisco, A., Ramamoorthy, S., Pausawasdi, N., & Tacey, K. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1141 · Cited by 31
Nuclear Factor-κB-Independent Regulation of Lipopolysaccharide-Mediated Interleukin-6 Biosynthesis
Haddad, J. J., & Fahlman, C. S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6556 · Cited by 31
Ruiz, P. A., Kim, S. C., Sartor, R. B., & Haller, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405032200 · Cited by 31
Ahmed, S., Jacob, B., Carsons, S. E., Leon, J. D., & Reiss, A. B. (2021) · Pharmaceuticals · doi:10.3390/ph15010011 · Cited by 30
Shin, J., Baek, S. R., Sohn, S. I., Cho, Y., & Lee, K. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23290 · Cited by 30
de la Fuente, V., Federman, N., Fustiñana, M. S., Zalcman, G., & Romano, A. G. (2014) · Hippocampus · doi:10.1002/hipo.22334 · Cited by 30
Treatment of endotoxaemia and septicaemia in the equine patient
Werners, A. H. (2016) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12329 · Cited by 28
Genetics of inflammatory bowel disease
Taylor, K. D., Rotter, J. I., & Huiying, Y. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_3 · Cited by 30
Tabary, O., Muselet-Charlier, C., Escotte‐Binet, S., Antonicelli, F. D., Hubert, D., Dusser, D. J., & Jacquot, J. P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63820-5 · Cited by 30
Cavallini, L., Francesconi, M. A., Zoccarato, F., & Alexandre, A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00640-2 · Cited by 30
Lee, S. H., Lee, C. W., Lee, J. W., Choi, M. S., Son, D. J., Chung, Y. B., Lee, C. K., Oh, K. W., Moon, D. C., Kwon, B. M., et al. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.07.028 · Cited by 30
Brannigan, A. E., Watson, R. W. G., Beddy, D. J., Hurley, H., Fitzpatrick, J. M., & O’Connell, P. R. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00008 · Cited by 30
Magri, J., Gasparetto, A., Conti, L., Calautti, E., Cossu, C., Ruiu, R., Barutello, G., & Cavallo, F. (2021) · Cells · doi:10.3390/cells10010108 · Cited by 31
Quiroga, M. F., Martínez, G., Pasquinelli, V., Costas, M. A., Bracco, M. M., Malbrán, A., Olivares, L., Sieling, P. A., & García, V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4120 · Cited by 29
Fröde, T. S., & Calixto, J. Β. (2000) · Inflammation Research · doi:10.1007/pl00000213 · Cited by 29
Regulation of nuclear factor‐κB in intestinal epithelial cells in a cell model of inflammation
Homaidan, F. R., Chakroun, I., & El-Sabban, M. E. (2003) · Mediators of Inflammation · doi:10.1080/09629350310001619681 · Cited by 29
Costas, M. A., Igaz, L. M., Holsboer, F., & ARZT, E. S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00113-0 · Cited by 29
Wiese, M. D., Alotaibi, N. M., O’Doherty, C., Sorich, M. J., Suppiah, V., Cleland, L. G., & Proudman, S. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.45 · Cited by 28
Inflammatory bowel disease and pregnancy: overlapping pathways
Nasef, N. A., & Ferguson, L. R. (2011) · Translational research · doi:10.1016/j.trsl.2011.12.002 · Cited by 29
Shirinsky, I. V., Polovnikova, O., Kalinovskaya, N., & Shirinsky, V. S. (2012) · Rheumatology International · doi:10.1007/s00296-012-2613-z · Cited by 28
Osako, M. K., Tomita, N., Nakagami, H., Kunugiza, Y., Yoshino, M., Yuyama, K., Tomita, T., Yoshikawa, H., Ogihara, T., & Morishita, R. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1077 · Cited by 28
MAG-EPA reduces severity of DSS-induced colitis in rats
Morin, C., Blier, P. U., & Fortin, S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00136.2015 · Cited by 28
Mortazavi‐Jahromi, S. S., Aslani, M., Omidian, S., Ahmadzadeh, A., Rezaieyazdi, Z., & Mirshafiey, A. (2019) · Drug Development Research · doi:10.1002/ddr.21619 · Cited by 28
Nakagawa, Y., & Akao, Y. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.04.004 · Cited by 28
Spironolactone induces apoptosis and inhibits NF-κB independent of the mineralocorticoid receptor
Sønder, S. U., Woetmann, A., Ødum, N., & Bendtzen, K. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0286-3 · Cited by 28
Fiebich, B. L., Hofer, T. J., Lieb, K., Hüell, M., Butcher, R. D., Schumann, G., Schulze‐Osthoff, K., & Bauer, J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00055-6 · Cited by 28
Different modes of NF-κB/Rel activation in pancreatic lobules
Algül, H., Tando, Y., Beil, M., Weber, C. K., von Weyhern, C., Schneider, G., Adler, G., & Schmid, R. M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00407.2001 · Cited by 28
Self-citationPosthumus, M. D., Limburg, P. C., Westra, J., Leeuwen, M. A. V., & van Rijswijk, M. H. (2002) · PubMed · Cited by 27
Matsui, N., Satsuki, I., Morita, Y., Inaizumi, K., Kasajima, K., Kanoh, R., Fukuishi, N., & Akagi, M. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.84.363 · Cited by 27
Spiik, A., Ridderstad, A., Axelsson, L.-G., Midtvedt, T., Björk, L., & Pettersson, S. (2002) · International Journal of Colorectal Disease · doi:10.1007/s00384-001-0366-3 · Cited by 27
Tacrolimus in corticosteroid-resistant ulcerative colitis
Matsuhashi, N., Nakajima, A., Watanabe, K., Komeno, Y., Suzuki, A., Ohnishi, S., Omata, M., Kondo, K., Usui, Y., Iwadare, J., et al. (2000) · Journal of Gastroenterology · doi:10.1007/s005350070065 · Cited by 27
The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy
Tarnowski, M., Paradowska‐Gorycka, A., Dąbrowska‐Żamojcin, E., Czerewaty, M., Słuczanowska-Głąbowska, S., & Pawlik, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1121233 · Cited by 26
Bafutto, M., de Almeida, J. R. D., Leite, N. V., Oliveira, Ê., Gabriel-Neto, S., & Rezende-filho, J. (2011) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032011000100008 · Cited by 28
Garcia, C. G., Kahn, S. A., Geraldo, L. H., Romano, I., Domith, I., Silva, D. C. L. E., Assunção, F. D. S., Ferreira, M. J., Portugal, C. C., de Souza, J. M., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0895-1 · Cited by 26
Signal transduction in rheumatoid arthritis
Piecyk, M., & Anderson, P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0194 · Cited by 26
Kim, Y. S., Kim, J. S., Jung, H. C., & Song, I. S. (2004) · Molecules and Cells · doi:10.1016/s1016-8478(23)13028-7 · Cited by 26
Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals
Lee, S., Jeon, S., Suk, K., & Lee, W. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03306.x · Cited by 25
Diarrhea as a Side Effect of Mesalamine Treatment for Inflammatory Bowel Disease
Goldstein, & DiMarino, A. J. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200007000-00014 · Cited by 25
Görgülü, S., Yağcı, G., Kaymakçıoğlu, N., Özkara, M., Kurt, B., Özcan, A., Kaya, O., Sadır, S., & Tufan, T. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3159-2 · Cited by 25
Park, S., Ku, S., Lee, E. S., & Kim, J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.02.002 · Cited by 25
Radi, Z. A., Heuvelman, D. M., Masferrer, J. L., & Benson, E. L. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1628-8 · Cited by 25
The protective role of NF-κB and AP-1 in arsenite-induced apoptosis in aortic endothelial cells
Tsou, T., Tsai, F., Wu, M. C., & Chang, L. W. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00239-4 · Cited by 25
Mei, Y., Zheng, Y., WANG, H., Gao, J., Liu, D., Zhao, Y., & Zhang, Z. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100299 · Cited by 24
Metadata
- Authors
- Wahl, C., Liptay, S., Adler, G., & Schmid, R. M.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Schmid, R M
- ORCID
- Schmid, R M
- Venue
- Journal of Clinical Investigation
- Published
- 1998-03-01
- Volume
- 101
- Issue
- 5
- Pages
- 1163-1174
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508669
- OpenAlex
- W2011496352
- Cited by
- 742
- References
- 48
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 17 · 2023: 18 · 2022: 18 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 19 · 2017: 11 · 2016: 15 · 2015: 19 · 2014: 17 · 2013: 24 · 2012: 19
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- sulfasalazine, NF-κB, IκBα degradation, IκBα phosphorylation, IκBα kinase, NF-κB nuclear translocation, 5-aminosalicylic acid, sulfapyridine, TNF-α, LPS, phorbol ester, proteasome, AP-1, immunosuppression, inflammatory bowel disease, rheumatoid arthritis, colon cancer cells
- MeSH terms
- Anti-Infective Agents, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Aspirin, Cells, Cultured, Colonic Diseases, Cystine, Epithelial Cells, Humans, Immunosuppression Therapy, Lipopolysaccharides, Phorbol Esters, Phosphorylation, Plasmids, Proline, Recombinant Proteins, Recombination, Genetic, Sulfasalazine, Sulfapyridine, Thiocarbamates, Transfection, Tumor Necrosis Factor-alpha, Blotting, Western, NF-kappa B, Transcription Factor AP-1, Fluorescent Antibody Technique, Indirect, Mesalamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review